1. Home
  2. HIMS vs AXSM Comparison

HIMS vs AXSM Comparison

Compare HIMS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hims & Hers Health Inc.

HIMS

Hims & Hers Health Inc.

HOLD

Current Price

$18.55

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

SELL

Current Price

$136.88

Market Cap

7.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HIMS
AXSM
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.5B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
HIMS
AXSM
Price
$18.55
$136.88
Analyst Decision
Hold
Strong Buy
Analyst Count
15
22
Target Price
$28.31
★ $265.86
AVG Volume (30 Days)
★ 12.7M
1.0M
Earning Date
11-09-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.56
EPS
★ N/A
N/A
Revenue
★ $2,347,637,000.00
N/A
Revenue This Year
$33.80
$49.13
Revenue Next Year
$23.08
$52.20
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 59.00
N/A
52 Week Low
$13.74
$123.00
52 Week High
$40.99
$260.19

Technical Indicators

Market Signals
Indicator
HIMS
AXSM
Relative Strength Index (RSI) 31.83 38.01
Support Level $13.74 $123.00
Resistance Level $30.72 $225.16
Average True Range (ATR) 2.12 7.91
MACD -0.78 2.11
Stochastic Oscillator 1.66 52.94

Price Performance

Historical Comparison
HIMS
AXSM

About HIMS Hims & Hers Health Inc.

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: